Medical use of dimethyl sulfoxide (DMSO).

BN Swanson - Reviews in clinical & basic pharmacology, 1985 - europepmc.org
DMSO is a clear odorless liquid, inexpensively produced as a by-product of the paper industry.
It is widely available in the USA as a solvent but its medical use is currently restricted by …

[HTML][HTML] Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma

…, JD Hamilton, BN Swanson… - New England journal …, 2018 - Mass Medical Soc
Background Dupilumab is a fully human anti–interleukin-4 receptor α monoclonal antibody
that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and …

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1, 2, 3, 4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective …

KS Atwal, BN Swanson, SE Unger… - Journal of medicinal …, 1991 - ACS Publications
In order to explain the potent antihypertensive activity of the modestly active (ICso= 3.2 mM)
dihydropyrimidine calcium channel blocker 5, we carried out drug metabolism studies in the …

[HTML][HTML] Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma

…, H Zhu, JD Hamilton, BN Swanson… - New England journal …, 2018 - Mass Medical Soc
Background Dupilumab is a fully human anti–interleukin-4 receptor α monoclonal antibody
that blocks both interleukin-4 and interleukin-13 signaling. Its effectiveness in reducing oral …

Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1, 4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

…, DM Floyd, S Moreland, BN Swanson… - Journal of medicinal …, 1990 - ACS Publications
Introduction Calcium channel blocking agents are widely used in the management of
angina pectoris and hypertension. 2 Within this class of cardiovascular agents, the …

[HTML][HTML] Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis

…, Y Assouline-Dayan, Q Zhao, Z Chen, BN Swanson… - Gastroenterology, 2020 - Elsevier
Background & Aims Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory
disease with no approved treatment in the United States. Dupilumab, a VelocImmune-derived …

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases

JD Hamilton, S Harel, BN Swanson… - Clinical & …, 2021 - Wiley Online Library
Background Type 2 inflammation is common in numerous atopic/allergic diseases and can
be identified by elevated biomarker levels. Dupilumab, a fully human monoclonal antibody, …

Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis

K Jonstam, BN Swanson, LP Mannent, LO Cardell… - Allergy, 2019 - Wiley Online Library
Background Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a type 2‐mediated
inflammatory disease associated with significant clinical, social, and economic burdens and …

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity

…, B BELHASSEN, BN SWANSON… - Annals of internal …, 1984 - acpjournals.org
The relationship of apparent steady-state serum concentrations of amiodarone and its
metabolite, desethylamiodarone, to therapeutic and toxic effects was assessed in 127 patients …

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin

…, E Ivashkiv, BN Swanson… - The Journal of …, 1990 - Wiley Online Library
The oral bioavailability of two HMG‐CoA reductase inhibitors, pravastatin and lovastatin,
was investigated in this randomized, two‐way crossover study. Twenty healthy men were …